Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan A Burger

Showing results (81-90 of 223) with videos related to

Pageof 23
Sort By:
Iscience|December 4, 2024
Mathematical multi-compartment modeling of chronic lymphocytic leukemia cell kinetics under ibrutinibMelanie Schulz, Sanne Bleser, Manouk Groels, et al.
Leukemia & Lymphoma|July 16, 2019
<i>Plesiomonas shigelloides</i> gastroenteritis in a patient with chronic lymphocytic leukemiaMansour Alfayez, Jan A Burger, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
British Journal of Haematology|December 19, 2014
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemiaPhilip A Thompson, Alessandra Ferrajoli, Susan O'Brien, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Blood|July 27, 2007
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemiaAndrea Bürkle, Matthias Niedermeier, Annette Schmitt-Gräff, et al.
British Journal of Haematology|March 11, 2004
Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - a single centre experienceRobert Zeiser, Jan A Burger, Thorsten A Bley, et al.
Blood|May 21, 2005
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cellsMeike Burger, Tanja Hartmann, Myriam Krome, et al.
Annals of Hematology|August 25, 2020
LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemiaWei Liu, Jan A Burger, Jie Xu, et al.
Leukemia & Lymphoma|July 30, 2019
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaLeslie A Andritsos, John C Byrd, Peter Cheverton, et al.
Pageof 23

Showing results (81-90 of 223) with videos related to

Sort By:
Pageof 23
Iscience|December 4, 2024
Mathematical multi-compartment modeling of chronic lymphocytic leukemia cell kinetics under ibrutinibMelanie Schulz, Sanne Bleser, Manouk Groels, et al.
Leukemia & Lymphoma|July 16, 2019
<i>Plesiomonas shigelloides</i> gastroenteritis in a patient with chronic lymphocytic leukemiaMansour Alfayez, Jan A Burger, Tapan Kadia, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 31, 2015
Three newly approved drugs for chronic lymphocytic leukemia: incorporating ibrutinib, idelalisib, and obinutuzumab into clinical practiceDavid S Sanford, William G Wierda, Jan A Burger, et al.
British Journal of Haematology|December 19, 2014
Trisomy 12 is associated with an abbreviated redistribution lymphocytosis during treatment with the BTK inhibitor ibrutinib in patients with chronic lymphocytic leukaemiaPhilip A Thompson, Alessandra Ferrajoli, Susan O'Brien, et al.
Blood|March 22, 2015
Secondary mutations as mediators of resistance to targeted therapy in leukemiaNaval Daver, Jorge Cortes, Farhad Ravandi, et al.
Blood|July 27, 2007
Overexpression of the CXCR5 chemokine receptor, and its ligand, CXCL13 in B-cell chronic lymphocytic leukemiaAndrea Bürkle, Matthias Niedermeier, Annette Schmitt-Gräff, et al.
British Journal of Haematology|March 11, 2004
Clinical follow-up indicates differential accuracy of magnetic resonance imaging and immunocytology of the cerebral spinal fluid for the diagnosis of neoplastic meningitis - a single centre experienceRobert Zeiser, Jan A Burger, Thorsten A Bley, et al.
Blood|May 21, 2005
Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cellsMeike Burger, Tanja Hartmann, Myriam Krome, et al.
Annals of Hematology|August 25, 2020
LPL deletion is associated with poorer response to ibrutinib-based treatments and overall survival in TP53-deleted chronic lymphocytic leukemiaWei Liu, Jan A Burger, Jie Xu, et al.
Leukemia & Lymphoma|July 30, 2019
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaLeslie A Andritsos, John C Byrd, Peter Cheverton, et al.
Pageof 23